Jennifer A. Ligibel, MD, senior physician in the Breast Oncology Center at Dana-Farber Cancer Institute, Boston, Massachusetts, talks with Lindsay L. Peterson, MD, MSCR, about results from the Breast Cancer Weight Loss (BWEL) Trial, which tested the efficacy of a weight loss intervention on metabolic and inflammatory biomarkers in women with obesity and breast cancer.
Estimated Read Time:
1 minute
SABCS Snippets: Results from the Breast Cancer Weight Loss (BWEL) Trial
Share
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
